- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
SYNO Market Currents
more »
-
December 14, 2011 More good news for Synovis (SYNO) shareholders, as FQ4 earnings rose a better-than-expected 83%, continuing the medical device company's streak of double-digit sales growth. Sales of its Peri-Strips for gastric bypass surgery, the biggest contributor to its top line, climbed 28%. Yesterday, SYNO agreed to be acquired by Baxter (BAX) for $28/share.
1 Comment[Healthcare, Earnings]
SYNO in Focus
more »
SYNO Related Articles
more »
SYNO News
more »
-
at MarketWatch.com (Dec 14, 2011)
-
at MarketWatch.com (Dec 13, 2011)
-
at MarketWatch.com (Dec 13, 2011)
-
at MarketWatch.com (Dec 13, 2011)
-
at MarketWatch.com (Aug 24, 2011)
SYNO Press Releases and Filings
more »
SYNO Latest Transcript
more »
SYNO Cramer
more »
Currently, there are no Cramer articles on SYNO.
SYNO Instablog posts
more »
SYNO vs. ETF Alternatives
Company Description
Currently, there's no company description for SYNO.